MS
Mark Leonard Singleton
SVP & CFO

Mark Leonard Singleton insider trades: Bioventus (BVS) stock sales

SVP & CFO, Bioventus Last trade Apr 11, 2025 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2023
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mark reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 11, 2025BVS↓ Sell$29K
Mar 24, 2025BVS↓ Sell$54K
Feb 18, 2025BVS↓ Sell$66K
Dec 23, 2024BVS↓ Sell$113K
Jun 21, 2024BVS↓ Sell$51K
Jun 17, 2024BVS↓ Sell$80K
Apr 11, 2024BVS↓ Sell$19K
Mar 22, 2024BVS↓ Sell$30K
Mar 24, 2023BVS↓ Sell$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BVS insiders

Open-market trades in the last 12 months

About Mark Leonard Singleton's insider trades

Mark Leonard Singleton is SVP & CFO at Bioventus (BVS). Since Mar 24, 2023, Mark has reported no open-market purchases and 9 sales worth $450K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (13 filings), grants and awards (5 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.